Sodium (S)-2-tetradecanamidopropanoate

Catalog No. :
ACMPTR842
CAS No. :
67395-95-3
Molecular Formula :
C17H32NNaO3
Molecular Weight :
321.44

IUPAC Name:sodium tetradecanoyl-L-alaninate

Sodium (S)-2-tetradecanamidopropanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$133.00Login to see priceIn stockInquiry
5g97%$406.00Login to see priceIn stockInquiry
10g97%$680.00Login to see priceIn stockInquiry
25g97%$1338.00Login to see priceIn stockInquiry
100g97%$4185.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium (S)-2-tetradecanamidopropanoate
IUPAC Namesodium tetradecanoyl-L-alaninate
MDL No.MFCD09751069
Molecular FormulaC17H32NNaO3
Molecular Weight321.44
SMILESC[C@@H](C([O-])=O)NC(CCCCCCCCCCCCC)=O.[Na+]
InChI KeyKCPRYTSOOWAFQV-RSAXXLAASA-M
SynonymSodium N-tetradecanoyl-L-alaninate;N-Tetradecanoyl-L-alanine monosodium salt;N-Butadecanoyl-L-alanine sodiuM salt;N-TETRADECANOYL-ALANINE MONO SODIUM SALT;Sodium N-tetradecanoyl-L-alaninate USP/EP/BP;Sodium (S)-2-tetradecanamidopropanoate;Sodium tetradecanoyl-L-alaninate;SodiumN-tetradecanoy
CAS No.67395-95-3
PubChem CID71306989

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMPTR842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMPTR842 route product structure diagram
    ACMPTR84267395-95-3 In Stock
Inquiry

2. ACMPTR842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPTR842 route product structure diagram
    ACMPTR84267395-95-3 In Stock
Inquiry

Comments (0)